Clover begins trials of COVID-19 vaccine with Dynavax and GSK adjuvants
The Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read moreThe Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read moreAlgernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read moreAstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read morePfizer Inc. has revealed revised clinical Phase 1b results on PF-06939926, an investigational gene therapy to treat Duchenne muscular dystrophy
Read moreNubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read moreDeciphera Pharmaceuticals, Inc. has revealed that QINLOCK™ (ripretinib) was formally authorised by the U.S. Food and Drug Administration (FDA) for
Read moreAstraZeneca and Merck & Co have received the FDA’s approval for Lynparza (olaparib) as 1st-line maintenance treatment with bevacizumab for
Read moreNew post-hoc analysis of six years of study data for Roche’s OCREVUS (ocrelizumab) shows earlier treatment initiation nearly halves the
Read moreUK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read moreJapanese research-driven pharmaceutical company Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. announced on April 28 that the
Read more